Core Insights - The article highlights the rapid consumption of ED (erectile dysfunction) drugs in China, with a market size approaching 10 billion yuan and annual sales exceeding 100 million pills, indicating a significant demand and a chaotic market environment [2][4]. Group 1: Market Dynamics - The ED drug market in China has experienced explosive growth since the expiration of the sildenafil patent in 2014, with an average annual growth rate exceeding 20% from 2015 to 2023, expanding from less than 3 billion yuan to nearly 10 billion yuan [4]. - The use of the "Viagra" brand name has led to a proliferation of products that are not necessarily of the same quality, as various companies exploit the brand's recognition through trademark licensing [5][6]. Group 2: Consumer Confusion - Consumers face challenges in distinguishing between genuine and counterfeit products, as many companies use the "Viagra" name while adhering to different quality standards, leading to widespread misinformation and potential fraud [6][7]. - The lack of a robust consumer protection mechanism complicates the situation, as consumers struggle to seek redress for misleading products due to the involvement of multiple parties, including brand owners, manufacturers, and sales platforms [6][7]. Group 3: Need for Education - There is a pressing need for improved public health education to address the misconceptions surrounding ED medications, as many consumers focus solely on the "Viagra" name rather than the actual product details [7][8]. - Medical professionals advocate for a more informed approach to purchasing ED drugs, emphasizing the importance of verifying product information and obtaining prescriptions from legitimate medical sources [7][8].